Delisting riskPopularity #3,152
CGC · NASDAQ · Drug Manufacturers - Specialty & Generic

Canopy Growth (CGC)

Sells cannabis products and Storz & Bickel vaporizers across Canadian and international medical markets.

$0.9473
vs last close+0.02 (+2.54%)
Loading prices…

Canopy Growth CorporationCGC
Health Care

Sells adult-use and medical cannabis in Canada, serves international medical markets, and offers Storz & Bickel vaporization products. Its U.S. THC assets are held through unconsolidated Canopy USA.

Canadian adult-use and medical cannabis, international medical cannabis, and Storz & Bickel vaporization products make up the operating platform. The Canadian business serves adult-use and medical customers, while international operations serve medical-cannabis markets. Storz & Bickel manufactures and sells vaporization devices within its operating platform.

Operations are centered in Canada but extend to international medical-cannabis markets. The U.S. THC portfolio sits within Canopy USA, which holds Acreage, Wana, and a majority interest in Jetty but is unconsolidated from Canopy Growth’s results. That separation is a defining structural fact of the business.

Company facts

CEOLuc Mongeau
ListedMay 24, 2018
ExchangeNASDAQ
HeadquartersSmiths Falls, Canada
CountryCanada
Employees960
CIK0001737927
ISINCA1380357048

Market cap$390.0M
EPS (ttm)−$0.4887
P/E (ttm)−1.89
ROE-32.8%
P/B0.7950
P/S1.70
Dividend yieldDiv yield
Beta1.43vs XLV 0.31

Price target$11.02+1,097.9%Average of 27 analysts
ConsensusHold11 of 27 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Nov 10, 2025BenchmarkUpgrade
Rating: Sell
Rating: Hold
Nov 10, 2025The Benchmark CompanyUpgrade
Rating: Sell
Rating: Hold

Next report
Nov 6, 26
in 45 days
EPS estimate
−$0.03
Revenue estimate
$58.5M
Fiscal quarter
Q2 FY27

EPSReportedEstimate

May '25Aug '25Dec '25Feb '26Mar '26Jun '26Aug '26Nov '26
Reported−$1.43−$0.22−$0.01−$0.10−$0.13−$0.29−$0.02Pending
Estimate−$0.46−$0.23−$0.11−$0.03−$0.04−$0.06−$0.04−$0.03
Surprise−209.6%+4.7%+93.6%−233.3%−218.6%−379.3%+50.0%

RevenueReportedEstimate

May '25Aug '25Dec '25Feb '26Mar '26Jun '26Aug '26Nov '26
Reported$65.0M$72.1M$47.9M$54.3M$54.6M$51.2M$57.2MPending
Estimate$70.2M$64.5M$51.1M$51.6M$51.9M$53.4M$58.2M$58.5M
Surprise−7.4%+11.8%−6.4%+5.2%+5.2%−4.1%−1.8%
Estimate−$0.03
ReportedDue Nov 6, 2026
Estimate$58.5M
ReportedDue Nov 6, 2026
View details

Debt to equity40.30%
Current ratio303.70%

ProfitabilityRevenueNet incomeNet margin

Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue$44.8M$53.2M$46.3M$51.3M$47.4M$72.8M$50.7M$57.7M
Net income−$91.3M−$86.7M−$157.1M−$29.5M−$1.2M−$61.1M−$111.8M−$10.4M
Net margin0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

GrowthOperating income

Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Operating income−$32.7M−$16.9M−$3.1M−$16.1M−$12.0M−$25.7M−$19.5M−$15.7M
YoY growthLoss narrowedLoss narrowedLoss narrowedLoss narrowedLoss widenedLoss widenedLoss narrowed

Balance sheet, Jun 30, 2026Cash & short-term investments $243.1M · Total debt $197.3M · Total assets $785.3M · Shareholders' equity $489.9M

Revenue
$57.7M
Operating income
−$15.7M
Net income
−$10.4M

Reported in CAD, converted at the latest exchange rate

View details

No dividends on record.

Institutions6.94%29.35M shares
232 holders · as of Jun 30, 2026
Insiders1.02%4.30M shares
9 holders · as of Sep 17, 2026
Strategic holders4.89%20.67M shares
1 holder · as of Apr 19, 2024
Other87.15%368.72M shares
remainder

423.04M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Constellation Brands, Inc.1Strategic10 percent owner
4.89%28.20Mfiled Apr 19, 2024
Toroso Investments, LLCInstitution
2.17%9.19Mas of Jun 30, 2026
Morgan StanleyInstitution
0.46%1.95Mas of Jun 30, 2026
Lazard Asset Management LLCInstitution
0.44%1.85Mas of Jun 30, 2026
Luc MongeauInsiderdirector, officer: Chief Executive Officer
0.41%1.72Mfiled Jun 22, 2026
  1. Constellation Brands, Inc.'s transaction reports restate only vehicles that traded; the 2020 ownership statement (28.20M) less the 7.53M net shares sold since is used instead.

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Sep 17, 2026Thomas Carlton Stewartofficer: See Remarks−25,755$0.9300
Aug 24, 2026Thomas Carlton Stewartofficer: See Remarks−2,231$1.47
Aug 24, 2026Christelle Gedeonofficer: See Remarks−13,344$1.47
Jun 26, 2026David Angelo Lazzaratodirector−22,674$0.9237
Jun 26, 2026M. Shan Atkinsdirector−3,197$0.9237
View details

Compare

CompanyPriceChange
Canopy Growth$0.9473+2.54%$390.0M1.7−20.8%
Tilray Brands$4.21+3.06%$456.3M0.4+25.5%
Aurora Cannabis$4.12+2.11%$249.6M1.2−34.0%
Organigram Global$1.13+0.89%$157.7M2.537.70.7+43.2%
Cronos Group$3.44+3.15%$1.24B18.457.35.1+58.4%
SNDL$1.40+1.82%$356.6M0.5−7.6%
Village Farms International$3.05+5.86%$350.8M15.315.41.5+6.8%
Median15.337.71.0+16.1%